Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Aims: Prospective evaluation of patients with a suspicion or diagnosis of Inflammatory bowel disease (IBD) to evaluate osophageal motility before and during therapy
Material and methods: The investigators prospectively perform manometry in patients with or with symptoms consistent with IBD. The investigators evaluate esophageal motility with high resolution manometry before, during and after IBD therapy. Clinical data are also collected to find possible correlations. The study do not modify the planned IBD therapy, but observe motility findings.
Oesophageal motility is measured with the high resolution manometry in order to detect pathologic peristaltic amplitude values among patient before and after therapy (mesalazine, steroids, biologicals) compared to the standard values detected among the normal population. Diagnosic intervention like oesophagoduodenoscopy, colonoscopy and stenosis ballon dilation are allowed as are part of the IBD therapy and follow up.
No other interventions are administered to participants during this study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Inflammatory bowel disease | Experimental | Patients with Crohn's disease and ulcerative colitis undergoing manometry |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Manometry | Device | Flexible tube catheter pressure measurement of oesophageal contractions. Measurement without any sedation, transnasal |
|
| Measure | Description | Time Frame |
|---|---|---|
| Manometry finding (peristaltic amplitude values mmHG) compared to normal population findings | 1 year | |
| Correlation with gastrointestinal symptoms to manometry findings (peristaltic amplitude values) | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Manometry findings (peristaltic amplitude values, mmHG) during therapy | 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Francesco Vitali, MD | Contact | francesco.vitali@uk-erlangen.de |
| Name | Affiliation | Role |
|---|---|---|
| Heinz Albrecht, MD | UK Erlangen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Erlangen Nuremberg | Recruiting | Erlangen | Bavaria | 91054 | Germany |
Not provided
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| ID | Term |
|---|---|
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D007410 | Intestinal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008365 | Manometry |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided